retatrutide type 2 diabetes phase 2 results Weight loss with as compared to currently licenced obesity Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Description
Weight loss is non-linear, the body adapts, and the scale is a blunt instrument that doesnt capture everything thats changing
At the end of the day, if you feel like youre struggling with managing your weight while having diabetes, its worth asking your healthcare team if they would be willing to prescribe one of these meds and see how it goes
All the extra fiber and lower sugar content make them a great choice
But thats actually not usually the case
Adults with obesity average a total of $1,861 more in medical costs annually than people of a healthy weight
These medications are given at different doses
